Yoko Tsukita

2PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 23, 2024
Multi-institutional study of osimertinib dose-optimization in non-small cell lung cancer patients with EGFR activating mutation aged 70 years or older ('MONEY' trial).

Yoko Tsukita, Masataka Taguri, Yasushi Goto

|Apr 21, 2022
First-line therapy in non-small cell lung cancer patients with EGFR activating mutations: a consideration of the clinical position of osimertinib based on the subset of Japanese patients in the FLAURA study.

Yoko Tsukita, Akira Inoue

Pageof 1

Frequent Collaborators

1 joint publications

Yasushi Goto

1 joint publications

Tomonori Mizutani